ArticleTherapeutic advances in neurological disorders2024

First line treatment with subcutaneous efgartigimod in impending myasthenic crisis: a case report.

Isabelle Kwiedor et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.